vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and AMDOCS LTD (DOX). Click either name above to swap in a different company.

AMDOCS LTD is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Alignment Healthcare, Inc.). AMDOCS LTD runs the higher net margin — 11.2% vs -1.1%, a 12.3% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 1.1%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 4.5%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Amdocs Limited is a multinational telecommunications technology company headquartered in Chesterfield, Missouri. The company specializes in software and services for communications, media and financial services providers and digital enterprises. Amdocs was founded in 1982 and is publicly traded on the Nasdaq stock exchange.

ALHC vs DOX — Head-to-Head

Bigger by revenue
DOX
DOX
1.2× larger
DOX
$1.3B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+43.3% gap
ALHC
44.4%
1.1%
DOX
Higher net margin
DOX
DOX
12.3% more per $
DOX
11.2%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
4.5%
DOX

Income Statement — Q4 FY2025 vs Q3 FY2024

Metric
ALHC
ALHC
DOX
DOX
Revenue
$1.0B
$1.3B
Net Profit
$-11.0M
$140.3M
Gross Margin
Operating Margin
-1.0%
14.1%
Net Margin
-1.1%
11.2%
Revenue YoY
44.4%
1.1%
Net Profit YoY
64.6%
-12.0%
EPS (diluted)
$-0.04
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
DOX
DOX
Q4 25
$1.0B
Q3 25
$993.7M
Q2 25
$1.0B
Q1 25
$926.9M
Q4 24
$701.2M
Q3 24
$692.4M
Q2 24
$681.3M
$1.3B
Q1 24
$628.6M
$1.2B
Net Profit
ALHC
ALHC
DOX
DOX
Q4 25
$-11.0M
Q3 25
$3.7M
Q2 25
$15.7M
Q1 25
$-9.1M
Q4 24
$-31.1M
Q3 24
$-26.4M
Q2 24
$-24.0M
$140.3M
Q1 24
$-46.5M
$118.5M
Operating Margin
ALHC
ALHC
DOX
DOX
Q4 25
-1.0%
Q3 25
0.8%
Q2 25
2.2%
Q1 25
-0.6%
Q4 24
-3.2%
Q3 24
-2.8%
Q2 24
-2.7%
14.1%
Q1 24
-6.5%
12.5%
Net Margin
ALHC
ALHC
DOX
DOX
Q4 25
-1.1%
Q3 25
0.4%
Q2 25
1.5%
Q1 25
-1.0%
Q4 24
-4.4%
Q3 24
-3.8%
Q2 24
-3.5%
11.2%
Q1 24
-7.4%
9.5%
EPS (diluted)
ALHC
ALHC
DOX
DOX
Q4 25
$-0.04
Q3 25
$0.02
Q2 25
$0.07
Q1 25
$-0.05
Q4 24
$-0.15
Q3 24
$-0.14
Q2 24
$-0.13
$1.21
Q1 24
$-0.25
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
DOX
DOX
Cash + ST InvestmentsLiquidity on hand
$604.2M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
Total Assets
$1.1B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
DOX
DOX
Q4 25
$604.2M
Q3 25
$644.1M
Q2 25
$503.8M
Q1 25
$479.5M
Q4 24
$470.6M
Q3 24
$381.0M
Q2 24
$363.7M
Q1 24
$301.7M
Total Debt
ALHC
ALHC
DOX
DOX
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
DOX
DOX
Q4 25
$179.3M
Q3 25
$161.9M
Q2 25
$141.0M
Q1 25
$108.1M
Q4 24
$99.9M
Q3 24
$114.5M
Q2 24
$123.7M
Q1 24
$130.9M
Total Assets
ALHC
ALHC
DOX
DOX
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.0B
Q1 25
$895.6M
Q4 24
$782.1M
Q3 24
$692.3M
Q2 24
$716.3M
Q1 24
$633.2M
Debt / Equity
ALHC
ALHC
DOX
DOX
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
DOX
DOX
Operating Cash FlowLast quarter
$-50.4M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
DOX
DOX
Q4 25
$-50.4M
Q3 25
$144.6M
Q2 25
$29.1M
Q1 25
$16.6M
Q4 24
$-8.7M
Q3 24
$26.2M
Q2 24
$23.5M
Q1 24
$-6.2M
Free Cash Flow
ALHC
ALHC
DOX
DOX
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
Q1 24
$-17.4M
FCF Margin
ALHC
ALHC
DOX
DOX
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Q1 24
-2.8%
Capex Intensity
ALHC
ALHC
DOX
DOX
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Q1 24
1.8%
Cash Conversion
ALHC
ALHC
DOX
DOX
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons